Acne Drug May Help in the Fight Against AIDS

June 21st, 2010

A cheap acne drug that’s been used for decades appears to target infected immune-system cells in which HIV lies dormant before coming back to life and spreading infection, researchers have found.

The authors of a new study say the antibiotic drug, minocycline, sold under names such as Minocin, could add to the HIV-fighting powers of existing AIDS drug regimens.

“The big challenge clinicians deal with now in this country when treating HIV patients is keeping the virus locked in a dormant state,” Janice Clements, professor of molecular and comparative pathobiology at the Johns Hopkins University School of Medicine, said in a news release. While existing drugs are “really effective in keeping down active replication, minocycline is another arm of defense against the virus,” she added.

Clements said minocycline targets immune cells known as T cells and makes it harder for them to reproduce. That, in turn, makes it harder for HIV to spread and eventually cause AIDS.

“This drug strikes a good balance and is ideal for HIV because it targets very specific aspects of immune activation,” Gregory Szeto, a graduate student who works at the Retrovirus Laboratory at Hopkins, said in the news release.

The study findings have been released online in advance of publication in the April 15 print issue of the Journal of Infectious Diseases.

SOURCE: Johns Hopkins Medicine.

Heat treatment found effective for plantar warts

June 14th, 2010

A targeted heat treatment appears to alleviate bothersome and sometimes painful plantar warts, researchers from China have found.

Plantar warts are skin growths on the soles of the feet caused by the human papillomavirus (HPV), which enters the body through tiny cuts and breaks in the skin. Plantar warts often develop beneath pressure points in the feet, such as the heels or balls of the feet.

Plantar warts can spread if not treated by over-the-counter or doctor-prescribed medications or salves, or by medical freezing, laser, or surgery. However, such treatments vary in their cure or pain-reducing capabilities.

Dr. Xing-Hua Gao, at No. 1 Hospital of China Medical University in Shenyang, and colleagues have found success treating plantar warts using a patented infrared heat-producing device, which heats warts to 44 degrees Centigrade (111 degrees Fahrenheit) without touching patients’ skin.

This approach, called local hyperthermia, cured plantar wart infections in nearly 54 percent of those treated, and reduced wart-related walking pain in 80 percent of the patients who initially had such pain, Gao’s team reports.

Local hyperthermia above 43 degrees Centigrade causes cell death, the researchers note in the Journal of Infectious Diseases. Local hyperthermia at 39 to 48 degrees Centigrade (about 102 to 118 degrees Fahrenheit) has been used to treat some cancerous tumors.

Gao’s team noted previous plantar wart cures using their device at about 45 degrees Centigrade (under 114 degrees Fahrenheit) among patients aware of their treatment.

In their current study, they kept 54 patients “blinded” to their treatment by telling them a red spot would or would not induce heat at their most painful or largest plantar wart.

Twenty-eight patients had one plantar wart held at 44 degrees Centigrade (111 degrees Fahrenheit) on average for 30 minutes. The researchers earlier identified this temperature as bearable without intolerable burning. Treatments ran on 3 consecutive days with follow up on 2 more days 2 weeks later. Another 26 patients of similar age and plantar wart infections had sham treatments.

After 3 months, 15 of the 28 heat-treated patients (nearly 54 percent) had no remaining sign of the treated wart, compared to only 3 of the 26 sham-treated patients (less than 12 percent). Twelve heat-treated individuals with initial pain reported decreased pain while walking, compared to only 2 sham-treated individuals.

If this approach proves effective in further studies, it “might be generally available in two or three years,” Gao noted in an email to Reuters Health.

SOURCE: The Journal of Infectious Diseases.

With Infertility May Come Sexual Dysfunction

June 7th, 2010

Infertile women face an increased risk for sexual dysfunction, a new study reports.

Stanford University researchers compared a group of infertile women, who averaged about 36 years old, with a group of fertile women, who averaged about 33 years old. Their weight and years of education were similar. The average length of infertility was 3.4 years, and 45 percent had been through in-vitro fertilization.

Scores on the Female Sexual Function Index showed that 40 percent of the infertile women were at risk for sexual dysfunction, compared with 25 percent of the others. Infertile women had significantly lower scores on desire and arousal, reported less frequent intercourse and masturbation and had lower scores for sex life satisfaction.

The findings were published online recently in the journal Fertility and Sterility.

“Stress is a significant contributing factor in female sexual dysfunction, and infertility can be a major cause of stress,” Dr. William Gibbons, president of the American Society for Reproductive Medicine, said in a news release from the society. “More research is needed on the many ways infertility can affect patients’ sexual functioning as well as to look for the effects of stress on the infertility process itself.”

SOURCE: American Society for Reproductive Medicine.

Coffee Drinking May Lower Stroke Risk

May 28th, 2010

Regular coffee drinking appears to reduce the risk of stroke, a new study indicates.

The study of 23,000 men and women who were followed for an average of 12 years found that “self-reported coffee consumption was inversely related to stroke risk,” said study leader Yangmei Li, an epidemiologist at the University of Cambridge in England.

Li was to present the findings Thursday at American Stroke Association’s annual stroke conference, in San Antonio.

Overall, people who reported any intake of coffee had a 27 percent lower risk of stroke than those who said they never drank java, the researchers reported. Drinking more coffee was not associated with a greater reduction in stroke risk.

“This association was consistent in subgroup analyses stratified by sex, age, social class, educational level, smoking status, alcohol drinking, tea drinking, physical activity, plasma vitamin C and diabetes status,” Li said.

And the reduced risk was “irrespective of the type of coffee consumed, caffeinated, decaffeinated, instant or ground,” Li said.

Daniel Lackland, a professor of epidemiology at the Medical University of South Carolina and a spokesman for the American Stroke Association, said the new research isn’t groundbreaking, but it does confirm previous findings.

“This is consistent with other studies that have looked at coffee drinking,” Lackland said. But, he added, “nobody really knows the mechanism.”

Studies have shown that coffee consumption is associated with a lower risk of developing type 2 diabetes — a major risk factor for stroke — and also with a reduced risk of heart disease, Lackland said. But those studies generally have not been carried out with rigorous methods, he said.

“Typically, they rely on self-reports, how much coffee you say you drink,” Lackland said. “But what might be two cups for me might be an entirely different two cups for you.”

So, there are no official suggestions that people drink coffee to lower their risk of stroke, Lackland said. “There has been no study designed to produce the kind of evidence needed to make recommendations,” he said.

SOURCES: Daniel Lackland, Ph.D., professor, epidemiology, Medical University of South Carolina, Charleston; presentation, American Stroke Association stroke conference, San Antonio
HealthDay

Antidepressant shows benefits for low sex drive

May 23rd, 2010

The antidepressant bupropion may hold promise for improving symptoms in younger women diagnosed with so-called hypoactive sexual desire disorder, a small study suggests.

The disorder, called HSDD for short, is diagnosed when a person has a persistently low interest in sex, and that disinterest is causing personal distress or relationship problems.

In the new study, Iranian researchers found that bupropion sustained-release (Wellbutrin SR) generally boosted sex drive among 116 women with HSDD who took the drug for 12 weeks. Compared with 116 women given an inactive placebo, their scores on a standard measure of sexual function were twice as high, according to findings published in the medical journal BJU International.

In some cases, low sex drive is related to underlying health conditions, like depression, or to side effects from some medications, like high blood pressure drugs or some antidepressants.

HSDD, however, refers to low sex drive that is not better accounted for by depression or other mental health disorders, and not caused by a medical condition or drug side effect.

As it stands, there is no treatment for HSDD that is widely accepted by women, according to the researchers on the new study, led by Dr. Mohammad Reza Safarinejad of Shahid Beheshti University in Tehran.

In Europe, a testosterone patch called Intrinsa is approved for treating HSDD in postmenopausal women. It is not approved in the U.S.

In an email, Safarinejad noted that studies have shown bupropion SR to improve sexual function in women who are having sexual side effects from using other antidepressants known as selective serotonin reuptake inhibitors (SSRIs).

Decreased libido is a potential side effect of SSRIs, which include drugs like sertraline (Zoloft), paroxetine (Paxil) and fluoxetine (Prozac). Bupropion has a different mechanism of action from SSRIs, targeting the nervous system chemicals dopamine and norepinephrine rather than serotonin.

For the current study, Safarinejad and colleagues randomly assigned 232 women between the ages of 20 and 40 to take either bupropion SR or a placebo every day for 12 weeks. All of the women had been diagnosed with HSDD and were free of depression or other major health problems.

The study received no drug industry funding, Safarinejad said.

At the outset, both groups of women had similar scores on a standard questionnaire gauging sexual function — just under 16, on average. The average score for healthy women with a regular partner is 33.6, Safarinejad said.

After 12 weeks, that score improved to 33.9 among women in the antidepressant group, versus 16.9 in the placebo group.

The most common side effects linked to bupropion included headache (affecting 9 percent of the group), insomnia and dry mouth (each affecting 7 percent), and nausea and muscle aches (each affecting 6 percent).

While the findings suggest that bupropion improves low sex drive, this is the first study to test the antidepressant in premenopausal women with HSDD.

“Further studies are needed to better elucidate the role of bupropion in HSDD,” Safarinejad noted.

Exactly why bupropion might improve sexual function is unclear. One theory attributes the effects to enhanced dopamine and norepinephrine activity; research suggests that dopamine is a key player in the brain’s “pleasure center,” being released in response to “rewards” like food and sex.

SOURCE: BJU International.

Skipping Insulin May Not Be Uncommon

April 30th, 2010

More than half of the people who need to take insulin to control their diabetes skip an injection now and then, a new study reports.

The researchers found that people with diabetes forgo their insulin injections for a number of reasons, including pain and embarrassment, and that their reasons vary depending on the type of diabetes they have.

“More and more people will be taking insulin, and it’s really important that they learn to manage this powerful medication effectively,” said the study’s lead author, Mark Peyrot, a professor of sociology at Loyola University Maryland and an assistant professor at Johns Hopkins University School of Medicine, both in Baltimore.

About one-fourth of the people who have diabetes — either type 1 or type 2 — take insulin, according to the study, which is published in the February issue of Diabetes Care. Insulin is a hormone that helps regulate blood sugar levels. Without insulin, the body’s cells can’t use sugar to fuel muscles. Insulin can only be taken through injections or an insulin pump.

People with type 1 diabetes, an autoimmune disease, no longer produce insulin on their own and depend on insulin injections to survive. People with type 2 diabetes still have some natural insulin, but they might not have enough or they might be resistant to insulin and require more than their body can provide.

Skipping a necessary insulin dose causes blood sugar levels to rise. And, with persistent high blood sugar, a person’s risk for serious complications, such as blindness and kidney failure, increases.

In their research, Peyrot and his colleagues asked 502 people with diabetes who used insulin to complete an Internet survey.

More than half of those surveyed, 57 percent, said they had intentionally missed an insulin dose, and 20 percent said they regularly skipped insulin injections.

Overall, people were more apt to miss an insulin dose if they were younger, had a lower income, had completed more schooling, had type 2 diabetes, did not follow a healthy diet, were required to take more injections, complained of injection pain, were embarrassed by the need for insulin or thought that the injections interfered with their daily life.

Not adhering to a good diet was the biggest reason that people with type 1 diabetes skipped their insulin dose — something that Peyrot said is not always a negative. That’s because people who get too much insulin are at risk of hypoglycemia (low blood sugar). If they skip a meal because they’re busy, for instance, they may need to skip the insulin dose they were scheduled to take so that their blood sugar levels don’t drop too low.

And, he explained, that’s probably why people with higher education levels were more likely to miss insulin. “It’s possible that it’s not ignorance, that it may be a thoughtful process in this case,” Peyrot said.

Among people with type 2 diabetes, the risk factors associated with insulin omission included age, education, income, pain and embarrassment.

“Some of these factors are modifiable,” Peyrot noted. Using insulin pens with fine-gauge needles, for example, could eliminate some of the pain and embarrassment associated with the injections, he said.

But he also described what he called a “disconnect” between diabetics and their doctors.

“Even when patients ask, providers might not be giving them enough help in overcoming modifiable risk factors,” Peyrot said. “Physicians need to be alert. Patients may tell you their problem rather than ask for help. It’s a hint.”

Katie Weinger, an investigator of behavioral and mental health research at Joslin Diabetes Center in Boston, said that missed insulin doses “is a really important issue in the treatment of diabetes.” She co-authored an accompanying editorial in the journal.

“Diabetes is a very challenging disease,” Weinger said. “You need to have a well-organized, unchaotic life in order to fit diabetes into it smoothly. And, for older people who’ve lived one way for 50 or 60 years, to have to change lifelong habits and take all these medications for high blood pressure, high cholesterol and their heart, and then you put insulin into the mix — it can be overwhelming,” she explained.

“People with diabetes don’t need to give up their quality of life, but they need to find a happy balance between treating and living well with diabetes,” she said. “And, when possible, treatment regimens may need to be simplified.”

SOURCES: Mark Peyrot, Ph.D., professor, sociology, Loyola University Maryland, Baltimore, and assistant professor, medicine, Johns Hopkins University School of Medicine, Baltimore; Katie Weinger, Ed.D., R.N., investigator, Joslin Diabetes Center, and assistant professor, psychiatry, Harvard Medical School, Boston;

Shot Protects Against Chickenpox After Exposure

April 25th, 2010

There is good news for people who have never had chickenpox or received the vaccine but are exposed to the virus: vaccination within five days of exposure can significantly reduce the risk of illness, or at least make it less severe, Spanish researchers say.

The study, published in the January issue of the Pediatric Infectious Disease Journal, found that out of 67 people who received the varicella zoster vaccine within five days of exposure to chickenpox, only 22 got sick. That’s about 62 percent fewer than would be expected to become ill with the disease. Based on past studies, 58 out of the 67 would be estimated to develop chickenpox.

The patients who did get chickenpox developed mild to moderate cases, suggesting that the vaccine is 79 percent effective in preventing moderate to severe disease. It didn’t matter if those vaccinated were children or adults: the vaccine appeared to have the same effectiveness, the study authors noted in a news release from the journal’s publisher.

“Available varicella vaccines administered within five days after exposure to chickenpox are effective in preventing chickenpox and highly effective in attenuating the disease,” Dr. Maria Brotons and colleagues of Hospital Universitario Vall d’Hebron, Barcelona, stated in the news release.

Chickenpox often causes mild illness, but the virus can cause complications and scarring. Young children and teens are especially at risk of developing rare complications that can be serious.

SOURCE: Lippincott Williams & Wilkins, news release

Premature Aging of the Brain Seen in HIV Patients

April 20th, 2010

Premature aging is striking the brains of people infected with the virus that causes AIDS, new research suggests.

It’s not clear if the virus or the drugs that treat it — or both — are contributing to the aging. But one thing is clear: The blood flow in HIV patients is about the same as in those of uninfected people who are 15 to 20 years older.

“The graying of the AIDS patient community makes this infection’s effects on the brain a significant source of concern,” study author Dr. Beau Ances, an assistant professor of neurology at Washington University in St. Louis, said in a university news release.

“Patients are surviving into their senior years, and a number of them are coming forward to express concerns about problems they’re having with memory and other cognitive functions,” Ances said.

An estimated 14 percent to 18 percent of all AIDS patients in the United States are more than 50 years old, and older people face one of the highest rates of new infections. By 2015, people over the age of 50 may account for more than half of all AIDS patients.

In the study, researchers used MRI scans to study the blood flow in the brains of 26 HIV-infected people and 25 other people who weren’t infected. The average age and education level of the participants were similar.

The researchers found reduced blood flow in the brains of younger HIV-infected patients who were infected recently, not just the older ones.

The study was released online in advance of publication in the Feb. 1 print issue of the Journal of Infectious Diseases.

SOURCE: Washington University in St. Louis, news release.

Birth Defects the Top Worry of Moms-to-Be

March 27th, 2010

Birth defects, preterm birth, breast-feeding and eating sushi are a few of the many concerns of pregnant women, according to a new March of Dimes survey.

The poll of about 1,200 mothers found that the leading cause of worry was birth defects (78 percent), followed by concern that stress in their life might harm their baby’s health (74 percent) and wondering whether their baby would be born too soon (71 percent).

About 70 percent said they thought about the pain of childbirth, 55 percent said they worried they wouldn’t get to the hospital on time, 60 percent were concerned they wouldn’t be able to breast-feed successfully, 59 percent wondered about their ability to lose weight after delivery and 59 percent also worried about getting pregnant in the first place. The leading food-related concern was sushi and fish (61 percent).

The findings were presented Dec. 9 at a meeting of the March of Dimes National Communications Advisory Council.

“Women should discuss all their questions with their doctors and should be concerned about their overall health — quit smoking, control their blood pressure, weight and any chronic diseases, such as diabetes — before they become pregnant so they will have a better chance at a healthy pregnancy,” Dr. Diane Ashton, deputy medical director of the March of Dimes, said in a news release.

Teen Methamphetamine Use, Cigarette Smoking at Lowest Levels in NIDA’s 2009 Monitoring the Future Survey (2)

March 20th, 2010

“The decline in cigarette smoking translates to longer, healthier lives for today’s young people,” said NIDA Director Dr. Nora Volkow. “And while it is disheartening that smokeless tobacco use is up again, the survey is telling us where to focus prevention efforts.”

Marijuana use across the three grades has shown a consistent downward trend since the mid-1990s, however, the decline has stalled, with rates at the same level as five years ago. In the 2009 survey, reported past year marijuana use was about the same as the previous year: 32.8 percent of 12th graders, 26.7 percent of 10th graders, and 11.8 percent of eighth graders. However, marijuana use is still down significantly from its peak in the mid-late 1990s.

The MTF survey also measures teen attitudes about drugs, including perceived harmfulness, perceived availability, and disapproval, which are often harbingers of abuse. For example, the percentage of eighth graders who view occasional marijuana smoking as potentially harmful is down to 44.8 percent, compared to 48.1 percent last year and 57.9 percent in 1991.

“The 2009 Monitoring the Future survey is a warning sign, and the continued erosion in youth attitudes and behavior toward substance abuse should give pause to all parents and policymakers,” said Director Gil Kerlikowske, of the White House Office of National Drug Control Policy. “Considering the troublesome data from other national and local surveys, these latest data confirm that we must redouble our efforts to implement a comprehensive, evidence-based approach to preventing and treating drug use.”

The data on some illicit drugs is encouraging. Past year use of cocaine decreased to 3.4 percent from 4.4 percent in 2008 among 12th graders, and past year use of hallucinogens also fell among high school seniors to 4.7 percent, down from last year’s 5.9 percent rate and significantly lower than its 2001 peak of 9.1 percent.

For the first time this year the survey also measured 12th graders’ use of the hallucinogenic salvia leaf, with 5.7 percent of high school seniors reporting past year use.

Perceived harmfulness of LSD, amphetamines, sedatives/barbiturates, heroin and cocaine have all increased among 12th graders, and the perceived availability of many illicit drugs has dropped considerably. For example, 33.9 percent of 12th graders reported this year that it is easy to get powder cocaine, down from 38.9 percent just a year ago. Similarly, 35.1 percent of 12th graders said ecstasy is easy to obtain, compared to 41.9 percent last year.

The 2009 MTF survey indicates a continuing high rate of non-medical use of prescription drugs and cough syrup among teens. Seven of the top 10 drugs abused by 12th graders in the year prior to the survey were prescribed or, purchased over the counter.

Nearly 1 in 10 high school seniors reported past year non-medical use of Vicodin, and 1 in 20 reported abusing Oxycontin, also a powerful opioid painkiller. Non-medical use of these painkillers has increased among 10th graders in the past five years.

For the first time this year the survey measured the non-medical use of Adderall, a stimulant commonly prescribed to treat ADHD. The survey reported that more than 5 percent of 10th and 12th graders reported non-medical use of the drug in the past year.

In addition, the survey recently started measuring how teens obtain the prescription drugs they took for non-medical use. Nineteen percent of 12th graders reported they got their drugs by a doctor’s prescription, and 8 percent reported buying them from a dealer. However, the vast majority — 66 percent — said they got the drugs from a friend or relative. Of these, 12 percent reported they “took” them; 21 percent reported “buying” them and 33 percent said they were “given” the drugs. Internet purchases do not appear to be a major source of drugs for this age group.

Researchers also report a softening of attitudes in some alcohol measures. Fewer 10th graders viewed weekend binge drinking (five or more drinks once or twice each weekend) as harmful, and fewer high school seniors disapproved of having one or two drinks every day. Alcohol use however, has decreased in the past five years across all three grades.

Overall, 46,097 students from 389 public and private schools in the eighth, 10th, and 12th grades participated in this year’s survey. Since 1975, the MTF survey has measured drug, alcohol, and cigarette use and related attitudes in 12th graders nationwide; eighth and 10th graders were added to the survey in 1991. Survey participants report their drug use behaviors across three time periods: lifetime, past year, and past month. The survey has been conducted since its inception by a team of investigators at the University of Michigan, led by NIDA grantee Dr. Lloyd Johnston. Additional information on the MTF, as well as comments from Dr. Volkow can be found at www.drugabuse.gov.